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The purpose of this study was to determine the effects of geometric uncertainties 
of patient position on treatments of multiple nonisocentric intracranial lesions. The 
average distance between lesions in patients with multiple targets was determined by 
a retrospective survey of patients with multiple lesions. Retrospective patient imaging 
data from fractionated stereotactic patients were used to calculate interfractional and 
intrafractional patient position uncertainty. Three different immobilization devices 
were included in the positioning study. The interfractional and intrafractional patient 
positioning error data were used to calculate the geometric offset of a lesion located 
at varying distances from the mechanical isocenter for treatments of multiple lesions 
with a single arc, assuming that no intrafractional position correction is employed 
during an arc rotation. Dosimetric effects were studied using two representative 
lesions of two sizes, 6 mm and 13 mm maximum dimensions, and prescribed to 
20 Gy and 18 Gy, respectively. Distances between lesions ranged from < 10 mm 
to 150 mm, which would correspond to a range of isocenter to lesion separations 
of < 10 mm to 75 mm, assuming an isocenter located at the geometric mean. In the 
presence of a full six degree of freedom patient correction system, the effects of the 
intrafractional patient positioning uncertainties were less than 1.8 mm (3.6 mm) for 
1σ (2σ) deviations for lesion spacing up to 75 mm assuming a quadratic summation 
of 1σ and 2σ. Without the benefit of a six DOF correction device, only correcting for 
three translations, the effects of the intrafractional patient positioning uncertainties 
were within 3.1 mm (7.2 mm) for 1σ (2σ) deviations for distances up to 75 mm. 
1σ and 2σ deviations along all six axes were observed in 3.6% and 0.3%, respec-
tively, of 974 fractions analyzed. Dosimetric effects for 2 mm and 4 mm offsets 
were most significant for the small lesion with minimum dose (Dmin) decreasing 
from 20 Gy to 13.6 Gy and 5.7 Gy and volume receiving the prescription (V20Gy) 
reducing from 100% to 57% and 16%, respectively. The dosimetric effects on the 
larger lesion were less pronounced with Dmin reducing from 18 Gy to 17.5 Gy and 
14.2 Gy, and V18Gy reducing from 100% to 98.3% and 85.4%, for 2 mm and 4 mm 
offsets, respectively. In the 1σ scenario (3.6% of patients) angular uncertainties in 
patient positioning can introduce 1.0 mm shifts in the location of the lesion posi-
tion at distances of 75 mm, compared to an isocentric treatment even with a full six 
DOF correction. Without the ability to correct angular positioning errors, a lesion 
positioned 75 mm away from the mechanical isocenter can be located in 3.6% of 
patients > 3.0 mm distant from the planned position. Dosimetric results depend upon 
the distance from isocenter and the size of the target. Single isocenter treatments for 
multiple lesions should be considered only when full six DOF corrections can be 
applied, the intrafractional immobilization precision is well quantified, and a PTV 
expansion is included for more distant lesions to account for unavoidable residual 
patient positioning uncertainties.
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I. INtRODUCtION
Recent studies have explored and demonstrated the use of volumetric-modulated arc therapies 
(VMAT) for the treatment of multiple cranial lesions in a single arc.(1-11) The primary benefit is 
the reduction of treatment time due to fewer isocenter setups, fewer imaging sequences, fewer 
treatment fields, and potentially fewer monitor units. The reduction in time has been suggested 
to increase the biological effectiveness of the dose(3) and will undoubtedly increase the clinical 
efficiency and patient comfort. 
When multiple lesions are treated with a single isocenter, the patient positioning uncertainty 
during the treatment will have different effects on the cumulative delivered dose compared to 
traditional isocentric treatment methods. Recent reports have analyzed the effects of rotational 
uncertainties on the delivered dose for isocentric lesions, but did not analyze lesions located at 
distances from isocenter.(12,13) Dose delivered to a lesion located at the mechanical isocenter of 
the treatment fields will be most affected by the linear translations of the patient position and less 
affected by small rotational uncertainties, unless the lesion has a particularly oblong shape. 
The situation is potentially different when the lesion is located far from the mechanical 
 isocenter of the treatment fields, as rotational patient uncertainties increasingly affect the 
accuracy of the location of the lesion. To date, none of the published reports detailing noni-
socentric stereotactic treatments have thoroughly discussed the effects of rotational setup 
uncertainties, although some abstracts have been presented.(14) Additionally, only two papers 
to date have presented full interfractional and intrafractional six degrees of freedom (DOF) 
data for their immobilization devices,(15,16) although some studies have measured intrafrac-
tional and laser-based uncertainties in six DOF.(17,18) We explore the effects of these rotational 
uncertainties on the accuracy of lesion positioning and dosimetric consequences when treating 
a nonisocentric lesion. 
 
II. MAtERIALS AND MEtHODS
A.  Intrafractional and interfractional patient positioning uncertainty 
A retrospective analysis of fractionated stereotactic patient positioning data as ascertained from 
orthogonal imaging was conducted and previously described in detail, including the bite block 
immobilization (modified-GTC, mGTC) specifications.(16) Forty-five random patients and 1002 
fractions were analyzed with 974 intrafractional measurements. Orthogonal kV images were 
acquired prior to the treatment of the first treatment field of each fraction to correct for initial 
setup discrepancies, and image pairs were acquired prior to each treated field to correct intra-
fractional motion. The intrafractional and interfractional positioning data were obtained using 
a fiducial based 2D/3D back-projection algorithm(16) and are tabulated in Table 1.
The distribution of intrafractional displacement was analyzed for all 974 intrafractional 
measurements to calculate the mean and standard deviations (SD) of the patient positioning 
uncertainty. Each fraction was also compared to the mean ± standard deviation for each of the 
six DOF to determine the displacement for each DOF. For all fractions analyzed, 3.6% of the 
fractions had displacements along all six DOF greater than 1 SD, and 0.3% had displacements 
along all six DOF greater than 2 SD.  
As a comparison, a summary of a BrainLAB Novalis (Feldkirchen, Germany) system is also 
included in the Results section, which includes two separate immobilizations and full six DOF 
interfracational and intrafractional uncertainties of the respective devices as measured using 
124  Winey et al.: Uncertainties in treatments of multiple nonisocentric lesions 124
Journal of Applied Clinical Medical Physics, Vol. 15, No. 3, 2014
the Novalis ExacTrac 2D/3D positioning system (BrainLAB AG).(15) Forty patients and 1222 
fractions were analyzed for interfractional motion and 400 fractions for intrafractional motion 
using the Novalis ExacTrac system prior to treatment and immediately following treatment. 
The ExacTrac positioning system employs a forward projection 2D/3D alignment system. The 
two immobilizations employed in the study(15) are an upper jaw support (UJS) mask system 
and a vacuum mouth piece (VMP) frame with occipital support. Greater description of the 
immobilizations and methods can be found in the respective reports.
B.  Geometric uncertainty for nonisocentric targets
For the calculation of the effect of patient positioning uncertainty at a distance, r, from the 
mechanical isocenter of the treatment field(s), we assume a simple geometric relationship detailed 
in Fig. 1, with the axes specified in Fig. 1. The position of the lesion center at distance r (mm) 
from isocenter can vary about the ideal position by a vector distance E(r) (mm). The definition 
of E(r) is separated into the angular (R) and linear (T) uncertainty components:
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Table 1. The intrafractional and interfractional accuracy and uncertainty of the mGTC frame(16) and the VMP and 
UJS immobilizations.(15) 
 Intrafraction Interfraction 
Dimension mGTC VMP UJS mGTC VMP UJS
Lateral (LAT), mm -0.12±0.37 -0.11±0.29 -0.11±0.28 -0.04±0.55 0.58±0.61 0.69±0.78
Ant/Post (AP), mm -0.09±0.37 -0.03±0.21 0.01±0.26 0.09±1.29 0.40±0.48 0.46±0.78
Cran/Caudal (CC), mm 0.11±0.41 0.13±0.30 0.05±0.58 0.09±1.13 -0.47±0.95 -0.01±1.47
Pitch (about LAT), ° 0.14±0.20 -0.02±0.14 -0.05±0.48 0.07±1.07 -0.42±0.38 -0.41±0.95
Yaw (about AP), ° 0.10±0.50 0.06±0.27 0.02±0.46 -0.08±0.51 0.06±0.38 0.18±0.80
Roll (about CC), ° 0.06±0.25 -0.02±0.15 0.02±0.49 0.05±0.59 -0.03±0.40 0.21±0.70
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and
   
 E(r) = ||r’ − r|| (7)
where r is the distance from mechanical isocenter to treatment target, and the six variables (μx, 
μy, μz, μth, μϕ, μψ) represent the average setup positioning discrepancy of the respective variable, 
and σt is the standard deviation of the respective variable, t, as derived from the retrospective 
patient data analysis. The standard deviation was multiplied by factor n for values of 0, 1, and 
2 which represents the average discrepancy and the average discrepancy plus 1 and 2 sigma 
deviations which incorporate 68% and 95% of the patient population for that variable. The 
summation of E(r) will occur much less frequently and was found in only 3.6% and 0.3% of 
all fractions treated for quadratic summation of 1 and 2 sigma uncertainty levels. 
The summation of the mean and standard deviations describes the limits of the positional 
error value within the statistical model described by the mean and standard deviations. The 
resulting E(r) value is not an average positional value, but a limit achieved when the positional 
errors are aligned. E(r) was calculated for all combinations of (x,y,z) E {−75,75},s.t.||r|| < 75 mm, 
and the maximum value of E(r) for each value of r was fit to generate a maximum curve for 
each scenario. The maximum error value of E(r) is a much less frequent occurrence in clinical 
situations, 3.6% and 0.3% of all cases for 1σ and 2σ limits. The order of the angular displace-
ments was varied and the effect of the order of multiplication in Eq. (6) did not significantly 
affect the magnitude of E(r).  
In Eq. (1), θ, ϕ, and ψ can be substituted with pitch, roll, and yaw in more clinical terms and 
x, y, and z can be substituted with Lat, CC, and AP directions.
C.  translations versus rotations and translations
The analysis of patient positioning error was divided into two scenarios present in many radia-
tion oncology centers: presence or nonpresence of rotational correction ability. For the scenario 
that a robotic couch or other rotational correction system is used for patient positioning and 
allows for rotational corrections, only the intrafractional rotational uncertainty is used in the 
Fig. 1. The coordinate system employed for this study. The distance r can vary as the distance between the mechanical 
isocenter (0,0,0) and the lesion center changes. E(r) is the magnitude of a shift in the location of lesion center (x, y, z). 
The insert provides a context of the coordinate system for a typical treatment couch.
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positioning error calculations, E(r). In the case that a six DOF patient positioning system is not 
accessible for intracranial cases, the initial rotational uncertainty was added to intrafractional 
rotational uncertainty for the rotational component of the geometric uncertainty calculation, 
since this interfractional rotational error would not be corrected. For the translational component 
of the positioning error, interfractional translational patient positioning error was assumed to 
be accurately corrected such that only the translational intrafraction uncertainty was included 
in the E(r) calculations.
For both cases, six DOF and non-six DOF, all positioning uncertainties are summed in order 
to project the total sum scenarios for the 1σ and 2σ cases. The uncertainties could fluctuate 
between ± and, therefore, the value of E(r) could be smaller than that displayed in the results. 
This point is particularly important to remember when the interfractional uncertainties are 
summed with the intrafractional uncertainties in the case of non-six DOF correction. 
D.  Separation of multiple lesions
A retrospective analysis of patient lesion locations was conducted. Thirty-three patients with a 
total of 108 lesions (range 2–17 lesions/patient) with multiple lesions treated in a single frac-
tion during the last year at MGH were analyzed. The distances between all lesions, D (mm), 
were recorded and were assumed to be the Euclidean vector distance between the geometric 
centers of lesion 1 and lesion 2, as listed in the treatment planning system. Assuming that the 
mechanical isocenter is located at the center of the two lesions, the distance between lesions 
was divided by two in order to obtain a distance from isocenter to lesion center. For patients 
with more than two lesions, the distance calculation was repeated for all possible combinations 
of lesions to simulate the case that only two lesions would be treated in a single fraction. 
E.  Dosimetric effects
A retrospective and representative planning study was conducted on two lesions to analyze the 
dosimetric consequences of a rotational intrafractional motion resulting in an error of patient 
positioning. The two lesions represented a smaller lesion (0.07 cc, 6 mm maximum dimension) 
and a larger, more typical size lesion (0.85 cc, 13 mm maximum dimension). Both lesions were 
treated in our clinic and were generally spherical. Six MV arc plans with cones were gener-
ated in CMS XiO (Elekta, Stockholm Sweden) to meet clinical prescriptions of 20 Gy to the 
smaller lesion and 18 Gy to the larger lesion with normalizations of 90% and no PTV margin 
expansion. The plans consisted of three arcs per lesion at roughly 45° couch kick separations 
and total arc degrees of 300.
Dosimetric effects were studied in the form of a DVH analysis for perfect alignment, a 
2 mm AP displacement and a 4 mm AP displacement. The AP direction was chosen to repre-
sent an error dominated by the pitch of the patient position during treatment which is the most 
dominant error observed in our clinic. Positional errors of 2 and 4 mm were selected to capture 
the 1σ and 2σ maximum effects at a isocenter-to-lesion distance of 75 mm when a six DOF 
correction is applied. 
 
III. RESULtS 
A.  Patient positioning uncertainty
A summary of the uncertainties of the mGTC immobilization device used in this report is listed 
in Table 1. As a comparison, the uncertainties from van Santvoort et al.(15) can be found in 
Table 1 for two immobilizations, upper jaw support (UJS) and vacuum mouth piece (VMP). 
The mGTC and the UJS secure the upper jaw without vacuum assistance, whereas the VMP 
utilizes a vacuum assist device in the upper jaw immobilization. 
For our data in Table 1, systematic errors of the alignment software and couch movement were 
also analyzed and were 0.1 mm/0.1° for translations and rotations. Hence, the intrafractional 
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patient position uncertainty presented in Table 1 is mostly due to the residual patient motion in 
the immobilization device during the course of treatment. The averages of the displacements 
were within the systematic error.
B.  Geometric uncertainties: Case 6 DOF system
Figure 2 details the net deviation of the lesion location as a function of the mechanical  isocenter 
to lesion center distance. Three lines are displayed for the average displacement, average plus 
1 SD, and average plus 2 SDs, for each of the three immobilizations, mGTC, UJS, and VMP, the 
last two from van Santvoort, et al.(15) The black lines (solid, dashed, dash-dotted) correspond to 
the mGTC frame of MGH. Table 2 provides a summary of the displacements at three discrete 
isocenter-to-lesion distances of 25, 50, and 75 mm.
At the zero separation, the net displacement is the baseline for the immobilization devices 
for isocentric treatments. The increase in displacement from the baseline is purely a function 
of the residual patient positioning uncertainty of the angular components of the immobiliza-
tion devices. As can be seen from Fig. 2, all three immobilizations have similar translational 
accuracies and uncertainties, but the angular uncertainties are different, a difference that is 
Fig. 2. The net displacement, E(r), for distance, r is displayed for a full six DOF correction. The average plus 2 SD (dashed) 
represents the net displacement that 99.7% of patients would fall within (i.e., somewhere between average and average 
plus 2 deviations 99.7% of patients would reside). The black lines correspond to the mGTC immobilization, and the two 
shades of gray correspond to the data plotted for van Santvoort et al.(15)
Table 2. The magnitude of E(r) (in mm) for the intrafractional uncertainties at distances of 25, 50, and 75 mm for 
each of the three immobilizations for the scenario that a six DOF correction has been applied.
 r (mm) Case mGTC VMP UJS
   μ 0.26 0.20 0.14
 25 μ +1σ 0.98 0.70 0.99
  μ +2 σ 1.77 1.22 1.89
   μ 0.34 0.23 0.16
 50 μ +1 σ 1.20 0.80 1.28
  μ +2 σ 2.16 1.42 2.46
   μ 0.42 0.25 0.19
 75 μ +1 σ 1.46 0.93 1.61
  μ +2 σ 2.63 1.65 3.11
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magnified at distance from isocenter. The VMP device does have a smaller rotational uncer-
tainty in general.
From the patient retrospective study, 3.6% of the patients had a displacement greater than 
the vector 1σ (i.e., the average vector displacement plus 1 SD line). The average plus 2 SD line 
represents the net displacement within which 99.7% of the patients would reside (i.e., 0.3% of 
the patients studied might have a vector displacement larger than the average plus 2 line). Along 
each of the six degrees of freedom, the data were Gaussian in distribution, but the summation 
of the errors is a random occurrence and only occurred in 3.6% and 0.3% of all patient fractions 
analyzed for 1σ and 2σ scenarios. In other words, only 0.3% of the fractions had positional 
errors along all six degrees of freedom greater than 2σ.
In Fig. 2 it can be seen that the angular uncertainty doubles the positioning uncertainty when 
approaching a distance of 75 mm (1.5–3.1 mm). The difference of immobilization devices is also 
seen as the two immobilization devices without vacuum assist have larger angular uncertainties 
which correspond to large positional uncertainties at larger distances from isocenter. 
Figure 2 also demonstrates the importance of a well-quantified immobilization device for an 
individual institution as the VMP μ+2σ line intersects with the μ+1σ line for the UJS device 
at a distance of 75 mm.
C.  Geometric uncertainties: Case of no six DOF system
Figure 3 displays the effects of angular uncertainties when there is no angular correction capabil-
ity in the patient positioning system. The baseline position (r = 0) is the same as in Fig. 2, but 
the slope of the lines are different as the angular interfractional uncertainties are added to the 
intrafractional angular uncertainties since the interfractional angular uncertainties are assumed 
to be uncorrected and, therefore, magnified during the treatment fraction. 
Similar to the previous scenario, the VMP device μ+2σ line crosses the μ+1σ of the UJS 
device, but at a distance of 25 mm instead of 75 mm. Additionally, the range of lesion displace-
ments increases to 7.2 mm at a distance of 75 mm for the 2σ scenario, which only occurs in 
0.3% of patient treatments. 
Fig. 3. The net displacement, E(r), for distance, r is displayed for a scenario without a full six DOF correction. The 
average plus 2 SD (dashed) represents the net displacement that 99.7% of patients would fall within (i.e., somewhere 
between average and average plus 2 deviations 99.7% of patients would reside). The black lines correspond to the mGTC 
immobilization, and the two shades of gray correspond to the data plotted for van Santvoort et al.(15)
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D.  Lesion separation
Figure 4 displays a histogram of the distances between lesions and assumed isocenters in 
patients with two targets. The range is < 5 mm to 75 mm assuming a mechanical isocenter 
location close to midpoint between lesions. Hence, the graphs in Figs. 2 and 3 cover the full 
range of distances observed in the institutions represented in this study. Thirty percent of the 
lesions (Fig. 4) were separated by a distance ≥ 100 mm or ≥ 50 mm separation from an isocenter 
located at the midpoint between two lesions.
Fig. 4. A summary of the displacements between lesions and isocenters in patients with multiple sites, assuming that the 
isocenter is equidistant from each lesion.
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E.  Dosimetric effects
Figure 5 displays the dose-volume histogram (DVH) curves for the two lesions and the three 
different isocenter positions (aligned, 2 mm AP error, and 4 mm AP error). The positional errors 
were selected to mimic the 1σ and 2σ errors of the mGTC at 50 mm distance from isocenter in 
the non-six DOF scenario. Dosimetric effects were most significant for the small lesion with 
minimum dose (Dmin) decreasing from 20 Gy to 13.6 Gy and 5.7 Gy and volume receiving 
the prescription (V20Gy) reducing from 100% to 57% and 16% for 2 mm and 4 mm offsets, 
respectively. The dosimetric effects on the larger lesion were less pronounced with Dmin reduc-
ing from 18 Gy to 17.5 Gy and 14.2 Gy and V18 Gy reducing from 100% to 98.3% and 85.4%, 
for 2 mm and 4 mm offsets, respectively. The effects were calculated assuming the lesion was 
offset for the entire treatment and clinical results would be dependent upon when the patient 
motion occurs during the fraction. 
 
IV. DISCUSSION
When treating nonisocentric lesions, the geometric uncertainty of the patient position becomes 
increasingly dependent upon the angular uncertainties of the immobilization and treatment posi-
tioning system. Proper quantification of an institution’s patient positioning is required in order 
to accurately incorporate the effects of rotational uncertainties into the patient immobilization 
and treatment planning process. 
The total uncertainty of the target location can be greater than 3.0 mm for 0.3% of patients 
for treatments of targets up to 75 mm from the mechanical isocenter for the mGTC frame and 
larger distances for the UJS and smaller distances for the VMP. Most patients will fall within 
the upper lines in Figs. 2 and 3, but adequate understanding of the uncertainty of the immobi-
lization device is essential. 
A distance- and lesion-dependent PTV could be incorporated into the treatment planning 
process in order to account for the additional setup uncertainty encountered when treating with 
a nonisocentric treatment field. Again, the immobilization and institution specific uncertainties 
must be quantified for adequate PTV expansions.
For institutions that do not have an accurate means of a full six DOF patient setup correc-
tion, nonisocentric treatments would include greater difficulty as angular uncertainties for some 
immobilizations can have a larger effect on the lesion displacement at distance from mechanical 
Fig. 5. A DVH demonstrating the effects of 2 mm and 4 mm intrafractional patient position errors. The dosimetric impacts 
of small rotations when lesions are distantly located from the isocenter are most pronounced for the small lesion and 
diminished in the large lesion. 
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isocenter when no angular correction is applied. Otherwise, a limit on the distance between the 
mechanical isocenter and the lesion center could be considered with adequate understanding 
of the immobilization uncertainty and a PTV expansion. 
Several groups are exploring and utilizing surface imaging techniques that have the potential 
of reducing the intrafractional uncertainties that might contribute to positional variations when 
the lesion is distant from the mechanical isocenter.(19-21)
The advantages of a single-arc VMAT treatment should not be diminished by this report. 
Uncertainties of patient positioning are unavoidable, but not impossible to overcome. Single-
arc treatments for multiple isocenters might greatly reduce the time of treatment, which could 
contribute to less patient position uncertainty. This study did not correlate length of treatment 
with angular uncertainty.
Shorter treatments might also be more beneficial for patient comfort and palliative treatments 
when a patient might not otherwise be willing to undergo treatment. 
Dosimetric impacts are an additional concern that cannot be generally addressed as they 
depend upon the patient, size and shape of the lesions, the planning system, the treatment 
planner, and mechanical specifications. We have presented two representative, nearly spheri-
cal lesions of two diameters. Size of the lesion greatly affects the overall dose distribution. 
Penumbras might cover some of the positional uncertainty, but the positional uncertainty must 
be quantified and understood in the planning process. 
Finally, this report displays the summed error scenarios when the errors of patient setup are 
summed directly and for coverage of 96.4%–99.7% of the patient population. Most patients 
will not have gross setup errors displayed by the μ+1σ and μ+2σ lines in Figs. 2 and 3, but the 
μ+2σ lines are presented to display the effects in the most difficult patients. Since pretreatment 
imaging is routinely employed, a triage system could be employed for patients that display 
larger angular uncertainties (only isocentric treatments) and those who have small angular 
uncertainties (nonisocentric treatments).
 
V. CONCLUSIONS
Residual angular uncertainties of patient positioning during intracranial treatments for treatment 
of nonisocentric lesions can add > 1 mm uncertainty in the location of the target with respect to 
the planned position when the distance between the isocenter and the lesion is greater than 75 mm 
in 3.6% of patients. Without six DOF positioning devices, the added positioning uncertainty 
increases to > 3 mm at 75 mm distance for 1σ scenarios. The patient immobilization device 
and setup uncertainties must be well determined in order to accurately model the dosimetric 
consequences. Proper modifications to the treatment planning process, particularly for small 
lesions, with the addition of a distance-dependent PTV or limitations to the use of nonisocentric 
treatment applications of VMAT for intracranial targets should be considered. 
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